Trifluridine/tipiracil plus bevacizumab in elderly patients with previously untreated metastatic colorectal cancer (KSCC1602): A multicenter, phase II clinical trial.

Eiji Oki,Akitaka Makiyama,Yuji Miyamoto,Masahito Kotaka,Hirofumi Kawanaka,Keisuke Miwa,Akira Kabashima,Masahiro Hamanoue,Takafumi Ohchi,Tomomi Kashiwada,Mototsugu Shimokawa,Hiroshi Saeki,Yoshito Akagi,Hideo Baba,Masaki Mori

Trifluridine/tipiracil plus bevacizumab in elderly patients with previously untreated metastatic colorectal cancer (KSCC1602): A multicenter, phase II clinical trial.

2019

Eiji Oki
Akitaka Makiyama
Yuji Miyamoto
Masahito Kotaka
Hirofumi Kawanaka
Keisuke Miwa
Akira Kabashima
Masahiro Hamanoue
Takafumi Ohchi
Tomomi Kashiwada
Mototsugu Shimokawa
Hiroshi Saeki
Yoshito Akagi
Hideo Baba
Masaki Mori

3548Background: Elderly patients are often intolerable in combination of cytotoxic agents. Recently, Trifluridine/tipiracil plus bevacizumab has been shown as good candidate for the vulnerable pati...

Keywords:

Colorectal cancer
Clinical trial
Bevacizumab
Pathology
Internal medicine
Oncology
Medicine
Trifluridine
Tipiracil

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations